Latest News
Guscio launches schools sport sponsorship programme
Guscio, an AIM-listed technology company focused on programmes in physical literacy and sporting assessment, has launched a sponsorship programme called Skills2Achieve Champions for schools around the UK.
Trump non-committal on Paris climate change agreement withdrawal
US president-elect Donald Trump said he is keeping an "open mind" on climate change and the Paris agreement which came into effect earlier this month, having previously promised to withdraw from it during his campaign.
Thomas Cook FY profit hit by terror attacks but EBIT beats estimates
Thomas Cook reported a drop in profit and revenue for the year to the end of September as the travel company took a hit from a series of terror attacks, but the group's underlying profit from operations came in ahead of expectations.
Hunting gushes higher on Credit Suisse upgrade
Hunting surged as Credit Suisse upped its stance on the stock to ‘outperform’ from ‘neutral’ and lifted the price target to 575p from 500p saying the company is turning a corner.
Markit's flash November eurozone PMIs beat expectations
Markit’s flash eurozone composite purchasing managers’ index rose to an 11-month high in November.
Redcentric appoints Peter Brotherton CFO
Redcentric, an IT managed services provider, has appointed Peter Brotherton as chief financial officer, company secretary and a director, effective from 28 November.
HICL Infrastructure completes acquisition of six education partnerships
Investor HICL Infrastructure Company has completed the acquisition of a portfolio of six education public–private partnerships from Germany’s Hochtief PPP Solutions for £22. 7m.
Vectura earnings surge as Skyepharma merger creates step-change
Inhaler maker Vectura's interim revenue have soared following the merger with rival Skyepharma and a launch of new products.
Europe open: Stocks little changed as investors digest PMIs
European stocks were little changed in early trade as investors digested some readings on eurozone services and manufacturing and continued to keep an eye on oil prices.
Daejan Holdings H1 profits rise; too early to assess Brexit impact
Interim pre-tax profits at real estate developer Daejan Holdings rose to £65. 1m from £58. 9m after accounting for the net valuation gain on investment properties of £38. 6m, up from £35. 5m in 2015.
Advent International to buy Brammer for £221.5m
Industrial supplies and services distributor Brammer has agreed to be bought by US private equity firm Advent International for 165p in cash per share, or around £221. 5m.
London open: Stocks in the black as investors eye Autumn Statement
Stocks in London rose in early trade, taking their cue from an upbeat session in the US, where the Dow closed above 19,000 for the first time ever, as investors eyed the Autumn Statement.
INPP increases debt facility to £400m
International Public Partnerships (INPP) said it had increased and extended its debt facility to £400m from £300m.
Micro Focus spikes on news of HPE Software's wider margins
Ahead of the £6. 6bn deal that will make it the UK's biggest software company, Micro Focus reported merger partner HPE Software's revenues were on the wane but margins were improving.
LondonMetric buys 8 distribution warehouses for £40m
LondonMetric Property said it had acquired eight 'last mile' distribution warehouse for a total of £39. 9m at a blended yield of 6. 2% and with a weighted average unexpired lease term of 9 years.
Allied Minds' HawkEye raises $11m in financing
Allied Minds’ subsidiary HawkEye 360 has raised $11m in new equity investment in a series A financing.
Softcat sees operating profit weighted towards H2
Softcat said on Wednesday that it has seen a good start in the first quarter but that it expects operating profit for the year to be weighted towards the second half.
Hammerson JV buys four European fashion outlets worth £502m
Property investor Hammerson has taken part in a joint-venture purchase of four fashion outlet centres in Europe worth a combined €587m (£502m), in order to expand in the territory.
GSK EGPA treatment meets endpoints in phase 3 study
GlaxoSmithKline said on Wednesday that both co-primary endpoints and all secondary endpoints were met in a “pivotal” phase III study investigating the efficacy and safety of it smepolizumab treatment in patients with relapsing and refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA).
London pre-open: Stocks seen higher on upbeat US cues; Autumn Statement eyed
Stocks in London were set for a higher, taking their cue from an upbeat session on Wall Street, where the Dow closed above 19,000 for the first time ever, as investors eyed the Autumn Statement.